These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

203 related items for PubMed ID: 18350504

  • 1. [Therapeutic options for mineral metabolism disorders in dialysis patients: a case report].
    Cozzolino M, Pasho S, Missaglia E, Crovetto C, Fallabrino G, Brancaccio D.
    G Ital Nefrol; 2008; 25(2):234-7. PubMed ID: 18350504
    [Abstract] [Full Text] [Related]

  • 2. Management of calcium, phosphorus and bone metabolism in dialysis patients using sevelamer hydrochloride and vitamin D therapy.
    Ishida M, Yao N, Yachiku S, Anzai T, Kobayashi T, Ishida H.
    Ther Apher Dial; 2005 Aug; 9 Suppl 1():S16-21. PubMed ID: 16109136
    [Abstract] [Full Text] [Related]

  • 3. 1alpha(OH)D3 One-alpha-hydroxy-cholecalciferol--an active vitamin D analog. Clinical studies on prophylaxis and treatment of secondary hyperparathyroidism in uremic patients on chronic dialysis.
    Brandi L.
    Dan Med Bull; 2008 Nov; 55(4):186-210. PubMed ID: 19232159
    [Abstract] [Full Text] [Related]

  • 4. Lanthanum: new drug. Hyperphosphataemia in dialysis patients: more potential problems than benefits.
    Prescrire Int; 2007 Apr; 16(88):47-50. PubMed ID: 17458039
    [Abstract] [Full Text] [Related]

  • 5. Control of hyperphosphatemia among patients with ESRD.
    Coladonato JA.
    J Am Soc Nephrol; 2005 Nov; 16 Suppl 2():S107-14. PubMed ID: 16251245
    [Abstract] [Full Text] [Related]

  • 6. [The use of xidifon for the correction of phosphorus-calcium metabolism in patients in the terminal stage of chronic kidney failure who are on programmed hemodialysis].
    Konstantinova OV, Ianenko EK, Danilkov AP, Pashkin IN.
    Urol Nefrol (Mosk); 1997 Nov; (3):23-5. PubMed ID: 9245050
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. New developments in the management of hyperphosphatemia in chronic kidney disease.
    McIntyre CW.
    Semin Dial; 2007 Nov; 20(4):337-41. PubMed ID: 17635825
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. [Hyperphosphatemia and cardiovascular risk in patients on dialysis].
    Basić-Jukić N, Kes P.
    Acta Med Croatica; 2004 Nov; 58(3):207-13. PubMed ID: 15503684
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. [New management of phosphocalcic abnormalities in dialysis patient].
    Delanaye P, Van Overmeire L, Dusbois BE, Krzesinski JM.
    Rev Med Liege; 2007 Nov; 62(5-6):360-5. PubMed ID: 17725207
    [Abstract] [Full Text] [Related]

  • 13. Calcium-based phosphate binders are appropriate in chronic renal failure.
    Friedman EA.
    Clin J Am Soc Nephrol; 2006 Jul; 1(4):704-9. PubMed ID: 17699276
    [Abstract] [Full Text] [Related]

  • 14. [Disorders of calcium and phosphorus metabolism in renal failure and nephrotic syndrome].
    Kubota M, Ohno T.
    Nihon Rinsho; 1982 Jul; 40(12):2673-9. PubMed ID: 6761460
    [No Abstract] [Full Text] [Related]

  • 15. Hyperphosphatemia among end-stage renal disease patients in developing countries: a forgotten issue?
    Afifi A, El-Sayed H, El-Setouhi M, Ahmed H, Khalifa N.
    Hemodial Int; 2005 Oct; 9(4):409-15. PubMed ID: 16219062
    [Abstract] [Full Text] [Related]

  • 16. [Altered calcium-phosphorus metabolism and low-protein diet].
    Santoro D, Cianciaruso B.
    G Ital Nefrol; 2008 Oct; 25 Suppl 42():S25-8. PubMed ID: 18828130
    [Abstract] [Full Text] [Related]

  • 17. [Disturbances of mineral metabolism and vascular calcifications in dialysis patients (review)].
    Malberti F, Ravani P.
    G Ital Nefrol; 2004 Oct; 21(3):238-44. PubMed ID: 15285002
    [Abstract] [Full Text] [Related]

  • 18. Phosphate binders in chronic kidney disease and end-stage renal disease: a patient-centered approach.
    Novak JE, Szczech LA.
    Semin Dial; 2009 Oct; 22(1):56-63. PubMed ID: 19000107
    [Abstract] [Full Text] [Related]

  • 19. [Monostatic localization of bone dystrophy in patients under hemodialysis for chronic renal insufficiency].
    Noè C.
    Arch Ital Urol Nefrol; 1971 Oct; 43(4):251-7. PubMed ID: 5130445
    [No Abstract] [Full Text] [Related]

  • 20. The case against calcium-based phosphate binders.
    Moe SM, Chertow GM.
    Clin J Am Soc Nephrol; 2006 Jul; 1(4):697-703. PubMed ID: 17699275
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 11.